Neck Pain

Asia Pacific CBD Patch Market Size, Share, Trends, Growth Overview 2021 by Segment, Company, Region, Industry Overview and Forecast to 2028

Published

3 years ago

February 24, 2022

Asia Pacific CBD Patch Market is expected to achieve market growth during the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market will grow at a CAGR of 18.1% during the forecast period of 2021-2028 and is expected to reach USD 64,169.10 by 2028. The increasing use of CBD products and patches for pain relief and consumer awareness is acting as drivers for the growth of the CBD patches market.

Download the exclusive sample report (350 pages PDF): To know the impact of COVID-19 on it [email protected] https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-cbd-patch-market&shrikesh

CBD patches are transdermal patches that contain cannabidiol (CBD). CBD is quickly delivered to the local area around the patch and then works its way through the bloodstream. By applying a patch directly to the skin, the CBD can bypass the digestive system and increase the bioavailability of the product.

Different types of patches are available in the market depending on the application. CBD patches are mainly used to treat chronic pain like neck pain, shoulder pain, lower back pain, and others. CBD patches are also used to treat mental health issues like insomnia, anxiety, and depression, among others. It relieves pain and keeps a person calm and stress-free, which is why the demand for the product in the market is increasing.

The increasing use of CBD patches to treat chronic pain is the main driver in the market. The side effects associated with CBD may prove to be a challenge, but expanding the field of research into medicinal uses of CBD patches is proving to be an opportunity. The restrictions imposed by government and medical bodies on the use of CBD for medical applications and the challenges faced by the impact of COVID-19 on the raw materials supply chain are the limiting factors.

For more insights into the Medical Cannabis market analysis, browse the study summary [email protected] https://www.databridgemarketresearch.com/reports/asia-pacific-cbd-patch-market

TOP KEY PLAYERS:
Ipsen Pharma
AbbVie Inc.
Mylan NV
Pfizer Inc.
Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
Teva Pharmaceutical USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
Takeda Pharmaceutical Company Limited
Sanofi
Arbor Pharma
Tolmar Pharmaceuticals, Inc.
GP-Pharm

Market scope and market size of CBD patches in Asia Pacific

The Asia Pacific CBD patch market is segmented by product, type, packaging, dosage, derivative, application, source type, end-user and distribution channel. The growth between segments will help you analyze growth niches and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of product, the CBD patch market is segmented into reservoir, matrix and layered drug-in-adhesive. In 2021, the reservoir segment is dominating the CBD patch market due to its use in various CBD applications.
On the basis of species, the CBD patch market is segmented into cannabis indica, hybrid and sativa. In 2021, the cannabis indica segment will dominate the CBD patch market due to its high CBD and low THC percentage compared to sativa and hybrid.
On the basis of packaging, the CBD patches market is segmented into two to five patches, single patches, and more than five patches. In 2021, the two to five patch segment is dominating the CBD patch market due to its high availability.
On the basis of dosage, the CBD patch market is segmented into under 30mg, 30-40mg, 40-50mg and over 50mg. In 2021, the sub-30mg segment is dominating the CBD patch market as the market is in its early stages and new consumers are starting with low dosage.
On the basis of derivatives, the CBD patches market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC), and others. In 2021, the cannabidiol (CBD) segment is dominating the CBD patches market due to the limitations on tetrahydrocannabinol (THC) content of 0.2-0.3% depending on the country of use.
On the basis of Application, the CBD Patches market is segmented into Chronic Pain, Anxiety, Arthritis, Mood Elevation, Neurological Pain and Others. In 2021, the chronic pain segment is dominating the CBD patch market due to the increase in chronic pain cases such as neck pain and shoulder pain.
On the basis of source type, the CBD patches market is segmented into natural and synthetic. In 2021, the natural segment is dominating the CBD patches market due to consumer trust in the natural products as herbal products are considered safe.
On the basis of end-use, the CBD patches market is segmented into home care, R&D centers, hospitals, clinics, rehabilitation centers, and others. In 2021, the home care segment will dominate the CBD patch market as the use of CBD products in medical care is not yet approved.
On the basis of distribution channel, the CBD patches market is segmented into dispensaries and dispensaries, online and brick-and-mortar stores. In 2021, the Dispensary and Dispensary segment will dominate the CBD patches market due to its well-established manufacturer-to-consumer supply chain.

Full report details with table of contents and [email protected] https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-cbd-patch-market&shrikesh

Points covered in the report:

The points discussed in the report are the major market players involved in the market.
The full profile of the companies is mentioned.
The report also includes the production, sales, future strategies and technological developments they are making.
The growth factors of the market are discussed in detail with the various end-users of the market being explained in detail.
The application areas of the market are also discussed to provide clients with a comprehensive view of the market.
The report contains the SWOT analysis of the market. Finally, the report contains the final part where the opinions of the industry experts are included.

Top list of health reports:

https://www.marketwatch.com/press-release/asia-pacific-apac-telehealth-market-2021-industry-size-share-demand-manufacturers-and-forecast-2028-2022-02-21?mod= search_headline

https://www.marketwatch.com/press-release/europe-laboratory-information-system-lis-market-industry-perspective-analysis-size-share-growth-segment-trends-and-forecast-2028-2022- 21.02?mod=search_headline

https://www.marketwatch.com/press-release/pharmaceutical-laboratory-information-management-systems-market-industry-perspective-analysis-size-share-growth-segment-trends-and-abbott-laboratories-agilent- technologies-inc-epic-systems-corporation-autoscribe-informatics-genologys-2022-02-21?mod=search_headline

https://www.marketwatch.com/press-release/europe-digital-therapeutic-dtx-market-2028-key-vendor-landscape-by-regional-output-demand-by-countries-and-future-growth- akili-interactive-labs-inc-atentiv-2morrow-inc-ayogo-health-inc-2022-02-21?mod=search_headline

https://www.marketwatch.com/press-release/nursing-education-market-2021-global-industry-analysis-by-key-players-segmentation-application-demand-and-national-university-of-singapore- duke-university-jamia-hamdard-johns-hopkins-university-2022-02-16?mod=search_headline

https://www.marketwatch.com/press-release/ehealth-market-2021-analysis-by-industry-trends-size-share-company-overview-growth-development-and-forecast-by-2028-2022- 02-16?mod=search_headline

https://www.marketwatch.com/press-release/north-america-digital-therapeutic-dtx-market-size-2028-by-application-type-manufacturers-across-north-america-europe-apac-south- america-mea-ayogo-health-incgingerclick-therapeutics-inccognoabetter-therapeutics-2022-02-16?mod=search_headline

https://www.marketwatch.com/press-release/internet-of-medical-things-iomt-market-dynamics-comprehensive-analysis-business-growth-revealing-key-drivers-prospects-and-breathometer-incbiotronikmedtronicmeru- healthboston-scientific-corporation-2022-02-16?mod=search_headline

https://www.marketwatch.com/press-release/digital-health-technologies-market-research-report-contains-key-players-industry-overview-supply-chain-analysis-and-ibm-koninklijke-philips- nvjohnson-johnson-services-2022-02-16?mod=search_headline

https://www.marketwatch.com/press-release/medical-device-testing-market-overview-2021-by-segments-products-companies-regions-statistics-industry-overview-sgs-sa-bureau-veritasintertek- group-plctuv-sud-2022-02-16?mod=search_headline

This market research report serves as a valuable source of information that helps companies to get a comprehensive overview of the current market trends, consumer demands and preferences, market situations, opportunities, and market status. The report provides the comprehensive study of the current wholesale market situation along with several market dynamics. Furthermore, the report also encompasses all the information including market definition, classifications, key developments, applications, and commitments as well as the detailed actions taken by the key players in terms of product launches, joint ventures, developments, mergers and acquisitions, and the impact of the same in terms of sales, import , export, sales and CAGR values.

About us:

Data Bridge Market Research has established itself as an unconventional and neoteric research and advisory firm with an unparalleled level of resilience and integrated approaches. We are committed to discovering the best market opportunities and promoting effective information to help your business thrive in the marketplace. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Contact us:

United States: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email – [email protected]

Some trending reports from the healthcare industry:

US Psychedelics Market: Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2028

Drug Addiction Treatment Market Forecast 2021-2028 by Regions, Type and Application with Sales & Revenue Analysis

North America Excipients Market – Global Industry Analysis, Competitive Insights and Key Drivers; Research Report 2021-2028

Nursing Education Market Size, Share and Forecast 2028 | Segmentation, key insights and company profiles

Fitness Apps Market Share Global Industry Growth, Size, Statistics, Opportunity and Forecast to 2028

https://www.marketwatch.com/press-release/physical-therapy-market-growth-probability-leading-vendors-and-future-scenario-during-forecast-period-2022-02-11?mod=search_headline

https://www.marketwatch.com/press-release/middle-east-and-africa-manual-resuscitators-market-2021-global-industry-analysis-by-key-players-segmentation-application-demand-and- Forecast to 2028-2022-02-11?mod=search_headline

https://www.marketwatch.com/press-release/laser-therapy-market-size-shaetrends-analysis-top-manufacturers-shares-growth-opportunities-statistics-forecast-to-2028-2022-02-11? mod=search_headline

https://www.marketwatch.com/press-release/internet-of-medical-things-iomt-market-share-application-analysis-regional-outlook-competitive-strategies-forecast-up-to-2028-2022- 02-11?mod=search_headline

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

Re: Chronic Pain: Management focuses on the individual, not the pain.

Published

2 years ago

July 17, 2023

AmericanChiro

Dear Editor

Chronic pain management focuses on the individual, not the pain.

I am very pleased with the review by Kang and colleagues [1]. I write as a spinal pain specialist whose patients had an average episode duration of pain pain of 2.5 years [2] for low back pain and 1.3 years for neck pain [3]. These studies confirm that Kang et. al. noted the significant extent of spinal and extraspinal pain, sleep disturbance, and psychological distress. I also recognize the ‘heartsinks’ who have seen many consultants for a variety of complaints, and those with hypersensitivity. I do accept that some patients need further investigations, but it can be done in a way that does not cause further anxiety. To ensure that intensive rehabilitation is not contraindicated. By showing a genuine interest in the family, job and interests of the individual, you can begin to build confidence and hope for the clinical path being recommended.

The review ignores trauma’s effects on some people, causing their pain to begin, and for others, a major factor. Thirteen percent of patients with neck pain who presented to my clinics had a traumatic origin with a missed break and significant psychological comorbidity. Subsequently, it became clear that post-traumatic distress (PTPD), [a term used because post-traumatic stress may require specialist knowledge for diagnosis] can be present in rheumatological practices [4] and with the increasing influx of refugees in the UK [5], more patients are being diagnosed with PTPD. This can have major effects on families [5]. PTPD is commonly seen in medicolegal situations where accidents have caused major destruction to the lives of individuals and their families, including divorce [6]; and is often associated mood disturbances [6].

Kang et. al. correctly mention that sleep disorders are important in the management chronic pain [1], however, two important aspects of a’sleep story’ must be identified. It is important to ask the individual what they are thinking about when they lie awake in bed at night. This may provide clues as to social or family stress. Second, you should ask about their nightmares and dreams, especially if they are unpleasant. These often involve reliving trauma or accidents. When asked about nightmares, people who deny any unpleasant memories during direct questioning may reveal clues. The presence of PTPD can be important because it opens up therapeutic opportunities with psychological support and medications.

My experience in rehabilitation medicine over the years has taught me that to fully assist our disadvantaged clients, social issues must be resolved before psychological issues, and psychological issues must be resolved before physical issues!

References

1. Kang Y et. al., Chronic Pain: Definitions and Diagnosis. BMJ (Clinical Research ed. ), 2023. 381: p. e076036.

2. Frank A. et al. A cross-sectional study of the clinical and psychosocial features of low back injury and the resulting work handicap: Use of the Quebec Task Force Classification. Int J Clin Pract, 2000; 54(10) p. 639-644.

3. Frank A, De Souza L and Frank C. Neck Pain and Disability: A Cross-sectional Survey of the Demographic and Clinical Characteristics of Neck Pain Seen in a Rheumatology Clinic. Int J Clin Pract 2005; 59(doi: 10.1111/j.1742-1241.2004.00237.x): p. 173-182.

4. McCarthy J. and Frank A. Posttraumatic psychological distress can present in rheumatology. BMJ 2002. 325(27 July): p. 221-221.

5. Frank A. Refugee status: a yellow-flag in managing back pain. BMJ 2007;334(13 Jan): p.58-58.

6. Frank A. Psychiatric effects of road traffic accidents: often disabling, and not recognised (letter). BMJ 1993, 307(13th Nov): p.1283.

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

Landmark Trial: Opioids No Better Than Placebo for Back Pain

Published

2 years ago

July 16, 2023

AmericanChiro

The first randomized controlled study testing the efficacy of a short course opioids for acute nonspecific neck/low back pain suggests that opioids do not relieve acute neck or low back pain in the short-term and can lead to worse outcomes over the long-term.

After 6 weeks there was no significant difference between the pain scores of patients taking opioids and those who took a placebo. After one year, the pain scores of patients who received placebos were slightly lower. After 1 year, opioid users were also at a higher risk of opioid abuse.

Senior author Christine Lin, Ph.D., from the University of Sydney told Medscape Medical News that this is a “landmark trial” with “practice changing” results.

Lin explained that “we did not have any good evidence before this trial on whether opioids are effective for acute neck or low back pain, but opioids are one of the most commonly prescribed medicines for these conditions.”

Lin stated that based on these results “opioids shouldn’t be recommended at any time for acute neck and low back pain,”

The results of the OPAL study have been published online in The Lancet on June 28.

Rigorous Test

The trial was conducted at 157 primary care and emergency departments in Australia, with 347 adults who experienced low back pain or neck pain for 12 weeks or less.

They were randomly allocated (1:1) to receive guideline-recommended care (reassurance and advice to stay active) plus an opioid (oxycodone up to 20 mg daily) or identical placebo for up to 6 weeks. Naloxone is given to prevent opioid-induced constipation, and to improve blinding.

The primary outcome was the pain severity at six weeks, as measured by the pain severity subscale (10-point scale) of the Brief Pain Inventory.

After 6 weeks of opioid therapy, there was no difference between placebo and opioid therapy in terms of pain relief or functional improvement.

The mean pain score was 2.78 for the opioid group at 6 weeks, compared to 2.25 for the placebo group. (Adjusted median difference, 0.53, 95% CI -0.00 – 1.07, P=.051). At 1 year, the mean pain scores of the placebo group were lower than those of the opioid group (1.8 and 2.4).

The risk of opioid misuse was doubled at 1 year for patients randomly assigned to receive opioid therapy during 6 weeks as compared to those randomly assigned to receive placebo during 6 weeks.

At 1 year, the Current Opioid Use Measure (COMM), a scale that measures current drug-related behavior, indicated that 24 (20%) patients from 123 patients who received opioids, were at risk for misuse. This was compared to 13 (10%) patients from 128 patients in a placebo group ( p =.049). The COMM is a widely-used measure of current aberrant drug related behavior among chronic pain patients who are prescribed opioid therapy.

Results Raise “Serious Questions”

Lin told Medscape Medical News that “I think the findings of the research will need to be distributed to doctors and patients so they receive the latest evidence on opioids.”

“We must reassure doctors and their patients that the majority of people with acute neck and low back pain recover well over time (normally within 6 weeks). Therefore, management is simple – stay active, avoid bed rest and, if needed, use a heat pack to relieve short term pain. Consider anti-inflammatory drugs if drugs are needed,” Lin added.

The authors of the linked comment state that the OPAL trial raises serious questions regarding the use of opioids for acute neck and low back pain.

Mark Sullivan, MD PhD, and Jane Ballantyne MD, from the University of Washington in Seattle, note that clinical guidelines recommend opioids to patients with acute neck and back pain when other drugs fail or are contraindicated.

As many as two thirds of patients may receive an opioid for back or neck pain. Sullivan and Ballantyne say that it is time to reexamine these guidelines.

The National Health and Medical Research Council (NHMRC), the University of Sydney Faculty of Medicine and Health (University of Sydney Faculty of Medicine and Health) and SafeWork SA funded the OPAL study. The authors of the study have not disclosed any relevant financial relationships. Sullivan and Ballantyne have served as board members of Physicians for Responsible Opioid Prescribing (unpaid), and paid consultants for opioid litigation.

Lancet. Online published June 28, 2023. Abstract

Join us on Facebook or Twitter for more Medscape Neurology News.

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

‘I tried acupuncture for back and neck pain even though I’m afraid of needles–and it’s literally the only thing that’s ever worked’

Published

2 years ago

July 15, 2023

AmericanChiro

To view this content, you must be logged-in as a subscriber.

4 WEEKS

$10

52 WEEKS

$130

Day Pass

$2.99

All plans include full website access and exclusive online extras.

Plans available in both print and digital formats

ALREADY a print subscriber?

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.